Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126539761 | 12653976 | 1 | I | 201606 | 20160810 | 20160816 | 20160816 | EXP | FR-009507513-1608FRA007446 | MERCK | 78.01 | YR | M | Y | 0.00000 | 20160816 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126539761 | 12653976 | 1 | PS | AERIUS | DESLORATADINE | 1 | Oral | 10 MG (5 MG, BID) | 21165 | 5 | MG | TABLET | BID | ||||||
| 126539761 | 12653976 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 1 G, 3 TO 4 TIMES A DAY | 0 | 1 | G | TABLET | TID | ||||||
| 126539761 | 12653976 | 3 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | FILM-COATED TABLET | QD | ||||||
| 126539761 | 12653976 | 4 | SS | PREVISCAN | FLUINDIONE | 1 | Oral | 15 MG, QOD | 0 | 15 | MG | SCORED TABLET | QOD | ||||||
| 126539761 | 12653976 | 5 | SS | PREVISCAN | FLUINDIONE | 1 | Oral | 20 MG, QOD | 0 | 20 | MG | SCORED TABLET | QOD | ||||||
| 126539761 | 12653976 | 6 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 5 MG, QD (2.5 MG 2 PUFFS QD) | 0 | 5 | MG | QD | |||||||
| 126539761 | 12653976 | 7 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3 TIMES A DAY | 0 | 300 | MG | TID | |||||||
| 126539761 | 12653976 | 8 | SS | TRIATEC (ramipril) | RAMIPRIL | 1 | Oral | 2.5 MG, BID | 0 | 2.5 | MG | SCORED TABLET | BID | ||||||
| 126539761 | 12653976 | 9 | SS | DIGOXINE NATIVELLE | DIGOXIN | 1 | Oral | 0.25 MG, QD | 0 | TABLET | QD | ||||||||
| 126539761 | 12653976 | 10 | SS | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 126539761 | 12653976 | 11 | SS | REPAGLINIDE. | REPAGLINIDE | 1 | Oral | 0.5 MG, BID | 0 | .5 | MG | BID | |||||||
| 126539761 | 12653976 | 12 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 126539761 | 12653976 | 13 | SS | FLUTIFORM | FLUTICASONE PROPIONATEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 2 INHALATIONS 2 TIMES A DAY | 0 | 2 | DF | INHALATION VAPOUR, SOLUTION | BID | ||||||
| 126539761 | 12653976 | 14 | SS | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 100 MG, PRN | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126539761 | 12653976 | 1 | Product used for unknown indication |
| 126539761 | 12653976 | 2 | Pain |
| 126539761 | 12653976 | 3 | Hypercholesterolaemia |
| 126539761 | 12653976 | 4 | Thrombosis prophylaxis |
| 126539761 | 12653976 | 6 | Asthma |
| 126539761 | 12653976 | 7 | Product used for unknown indication |
| 126539761 | 12653976 | 8 | Hypertension |
| 126539761 | 12653976 | 9 | Atrial fibrillation |
| 126539761 | 12653976 | 10 | Hypertension |
| 126539761 | 12653976 | 11 | Type 2 diabetes mellitus |
| 126539761 | 12653976 | 13 | Asthma |
| 126539761 | 12653976 | 14 | Asthmatic crisis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126539761 | 12653976 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126539761 | 12653976 | Eosinophilia | |
| 126539761 | 12653976 | Lung disorder | |
| 126539761 | 12653976 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |